Study S000459

An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder Using fMRI to Identify Novel Neural Biomarkers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07693608
Acronym: TRI-MR
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: ENROLLING_BY_INVITATION
Enrollment: 45
Start: 2026-08-19
Primary completion: 2030-02-01
Lead sponsor: University of Texas Southwestern Medical Center
Conditions: Obesity; Methamphetamine Use Disorder; Cocaine Use Disorder; Stimulant Use Disorders
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Effect of tirzepatide on self-reported use of stimulants [32 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.